Phenotype by symptoms + exacerbations → GOLD group A/B/E; inhaler escalation (LAMA → LABA/LAMA → triple if eos ≥ 300 or ongoing exacerbations); pulmonary rehab + smoking cessation + vaccines.
Authored pathway active · chronic-obstructive-pulmonary-disease-copd.outpatient
Phenotype by symptoms + exacerbations → GOLD group A/B/E; inhaler escalation (LAMA → LABA/LAMA → triple if eos ≥ 300 or ongoing exacerbations); pulmonary rehab + smoking cessation + vaccines.
Guidelines: GOLD 2026 Report · ATS/ERS 2023 Pulmonary Rehabilitation · CDC/ACIP 2026 Adult Vaccination Schedule (RSV, PCV20, influenza)
Phenotypes (4)
- COPD GOLD Group A/B (Low Risk, Low/High Symptoms)
- COPD GOLD Group E (High Risk, >= 2 Exacerbations or 1 Hospitalization)
- Acute Exacerbation of COPD
- End-Stage COPD — Long-Term Oxygen Therapy
Pathway-scoped symptom and exam intake
Test this pathway's ROS and differential links
Uses LR engine pulm.copd.core.v1, then routes suggested engines into the workspace.
19-panel workspace
chronic-obstructive-pulmonary-disease-copd · OutpatientStart patient workup
Open a scratch or linked encounter, add active problems, then keep labs, fluids, acid-base, and electrolyte tools beside the main workspace instead of losing context.
Encounter and problems
No encounter open. Add a problem to create a scratch encounter when none is open.
Multi-window tools
Unified
labs + fluids + acid-base
Labs
fast lab analyzer
Fluid
resuscitation and balance
Electrolytes
Na/K/Mg/Phos/Ca
ABG/VBG
compensation and mixed disorders
Popular entry points
6 quick-startsOr jump straight to the atlas
The Engine Atlas covers every authored disease package with setting chips and pathway badges. Open any engine to load its 19-panel workspace, backed by phenotype-aware reasoning and monitored by the Flow Assistant.